PREDNISOLONE EVOLUGEN 20 mg, orodispersible tablet 20 tablets
Active ingredients: Prednisolone sodium metazoate, Prednisolone
Commercialized according to BDPMDispensing in France: Prescription only
Orodispersible tablet20 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- PREDNISOLONE EVOLUGEN 20 mg, comprimé orodispersible
- Pharmaceutical form
- comprimé orodispersible
- Route of administration
- orale
- Presentation description
- plaquette(s) thermoformée(s) PVC polyéthylène aluminium PVDC de 20 comprimé(s)
- Marketing authorisation holder
- EVOLUPHARM
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 6 Jun 2024
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
65424299CIP73910932CIP133400939109329Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| PREDNISOLONEcomprimé | 20 mg · un comprimé | FT |
| MÉTASULFOBENZOATE SODIQUE DE PREDNISOLONEcomprimé | 31,44 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.